Breaking News Instant updates and real-time market news.

QDEL

Quidel

$58.80

1.7 (2.98%)

18:01
06/19/19
06/19
18:01
06/19/19
18:01

Quidel receives 510k clearance for Triage TOX Drug Screen

Quidel Corporation announced that Quidel has received 510k clearance from the Unites States Food and Drug Administration to market the Quidel Triage TOX Drug Screen, 94600, a fluorescence immunoassay for the qualitative determination of the presence of drug and/or metabolites in human urine of up to 9 drug assays. The test is to be used with Quidel's Triage MeterPro instrumented system. "We believe that our latest diagnostic screening test can play an important role in providing fast, diagnostic answers to healthcare providers in the emergency and urgent care settings," said Douglas Bryant, president and chief executive officer of Quidel Corporation. "We are very pleased to receive clearance from the FDA for our Quidel Triage TOX Drug Screen, 94600 toxicology test and are optimistic that this assay will drive growth in the Triage business by delivering a more reliable, higher quality product to the customer, as well as creating further growth in the installed base of MeterPro instruments out in the field."

QDEL Quidel
$58.80

1.7 (2.98%)

12/10/18
CHLM
12/10/18
DOWNGRADE
Target $51
CHLM
Hold
Quidel downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Alexander Nowak downgraded Quidel to Hold from Buy and lowered his price target to $51 from $80 following a "surprising" court ruling that the "Beckman BNP non-compete agreement is void". The analyst states that since BNP is about half of the company's EBITDA, the development represents a "material blow to the company". Nowak further notes that Quidel's "multiple expansion was its diversification away from flu", and the latest news makes its model "once-again, levered to the flu season".
12/11/18
ADAM
12/11/18
NO CHANGE
Target $70
ADAM
Buy
Quidel price target cut to $70 at Canaccord, says buy on weakness
Canaccord analyst Mark Massaro lowered his price target on Quidel to $70 from $80 and recommends investors buy shares on weakness after a judge from the Superior Court of San Diego ruled in summary judgement that a provision in the Beckman/Quidel deal restricting Beckman's ability to commercialize an alternative BNP or NT-Pro BNP assay was void. In a research note to investors, Massaro says that while Quidel will likely bear an ear-term legal overhang, he views the ~22% plunge in shares since Friday as "overblown," in part since the precedent "Edwards" case that the judge referenced in the Beckman-Quidel case appears "inappropriate"; Quidel is appealing this case; and the time it would take Beckman to realistically compete against Quidel is about 2-5 years.
01/04/19
ADAM
01/04/19
NO CHANGE
ADAM
Illumina, Exact Science among top Diagnostics picks for 2019 at Canaccord
Canaccord analyst Mark Massaro introduced his top picks for 2019 in the Diagnostics and Tools space as he expects new tests will generate clinical and economic utility to patients and payors, which will pace positive returns in 2019. His top picks include Illumina (ILMN) with a $375 price target, Exact Sciences (EXAS) with an $87 price target, Heska (HSKA) with a $123 target, Natera (NTRA) with a $25 target, OraSure (OSUR) with an $18 target and Quidel (QDEL) with a $70 price target.
02/14/19
CHLM
02/14/19
NO CHANGE
Target $63
CHLM
Hold
Quidel price target raised to $63 from $51 at Craig-Hallum
Craig-Hallum analyst Alexander Nowak raised his price target for Quidel to $63 from $51 following quarterly results. The analyst reiterates a Hold rating on the shares.

TODAY'S FREE FLY STORIES

SYF

Synchrony

$36.09

0.54 (1.52%)

, PYPL

PayPal

$119.87

1.07 (0.90%)

08:00
07/19/19
07/19
08:00
07/19/19
08:00
Hot Stocks
Synchrony says average active accounts were up 9% in Q2 »

Synchrony (SYF) says it…

SYF

Synchrony

$36.09

0.54 (1.52%)

PYPL

PayPal

$119.87

1.07 (0.90%)

WMT

Walmart

$114.68

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 24

    Jul

  • 15

    Aug

  • 25

    Sep

  • 13

    Nov

NFLX

Netflix

$325.14

-37.36 (-10.31%)

08:00
07/19/19
07/19
08:00
07/19/19
08:00
Options
Netflix call buyer realizes 3% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

SKX

Skechers

$34.75

0.35 (1.02%)

07:59
07/19/19
07/19
07:59
07/19/19
07:59
Recommendations
Skechers analyst commentary  »

Skechers price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$56.27

1.67 (3.06%)

07:55
07/19/19
07/19
07:55
07/19/19
07:55
Hot Stocks
State Street boosts productivity savings for FY19 to 4.5% from 4% »

State Street says it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

WNS

WNS Holdings

$62.34

3.8 (6.49%)

07:53
07/19/19
07/19
07:53
07/19/19
07:53
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

07:52
07/19/19
07/19
07:52
07/19/19
07:52
Recommendations
Microsoft analyst commentary  »

Microsoft still has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

07:51
07/19/19
07/19
07:51
07/19/19
07:51
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WW

WW

$25.18

1.23 (5.14%)

07:49
07/19/19
07/19
07:49
07/19/19
07:49
Upgrade
WW rating change  »

WW upgraded to Buy at DA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$136.29

0.06 (0.04%)

07:49
07/19/19
07/19
07:49
07/19/19
07:49
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

DOW

Dow Inc.

$51.76

0.15 (0.29%)

07:48
07/19/19
07/19
07:48
07/19/19
07:48
Initiation
Dow Inc. initiated  »

Dow Inc. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 24

    Sep

NGVT

Ingevity

07:44
07/19/19
07/19
07:44
07/19/19
07:44
Downgrade
Ingevity rating change  »

Jefferies downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

INDB

Independent Bank

$73.31

0.56 (0.77%)

07:44
07/19/19
07/19
07:44
07/19/19
07:44
Upgrade
Independent Bank rating change  »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

KBR

KBR

$25.28

0.36 (1.44%)

07:43
07/19/19
07/19
07:43
07/19/19
07:43
Upgrade
KBR rating change  »

KBR upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

MDR

McDermott

$10.20

-0.25 (-2.39%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Hot Stocks
McDermott awarded pre-FEED contract by YPF in Argentina »

McDermott has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

ADTN

Adtran

$12.12

-3.72 (-23.48%)

, DTE

DTE Energy

$131.39

1.27 (0.98%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Recommendations
Adtran, DTE Energy analyst commentary at MKM Partners »

Adtran price target…

ADTN

Adtran

$12.12

-3.72 (-23.48%)

DTE

DTE Energy

$131.39

1.27 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

  • 02

    Oct

AXS

Axis Capital

, ACGL

Arch Capital

$38.24

0.12 (0.31%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Recommendations
Axis Capital, Arch Capital, Travelers, Hartford Financial analyst commentary at Buckingham »

Buckingham upgrades Axis…

AXS

Axis Capital

ACGL

Arch Capital

$38.24

0.12 (0.31%)

TRV

Travelers

$152.69

0.27 (0.18%)

HIG

Hartford Financial

$57.90

0.24 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 30

    Jul

  • 31

    Jul

  • 02

    Aug

  • 06

    Aug

07:40
07/19/19
07/19
07:40
07/19/19
07:40
General news
Treasury Market Outlook: Treasuries are a little weaker »

Treasury Market Outlook:…

WNS

WNS Holdings

$62.34

3.8 (6.49%)

07:39
07/19/19
07/19
07:39
07/19/19
07:39
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

07:38
07/19/19
07/19
07:38
07/19/19
07:38
Recommendations
Intuitive Surgical analyst commentary at Canaccord »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

AXP

American Express

$128.40

1.355 (1.07%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Earnings
American Express backs FY19 adj. EPS view of $7.85-$8.35, consensus $8.13 »

Backs FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

EXPO

Exponent

$61.63

0.83 (1.37%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Recommendations
Exponent analyst commentary  »

Exponent price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

STT

State Street

$56.27

1.67 (3.06%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Earnings
State Street reports Q2 EPS $1.42, consensus $1.39 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

WW

WW

$25.18

1.23 (5.14%)

07:36
07/19/19
07/19
07:36
07/19/19
07:36
Upgrade
WW rating change  »

WW upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBBP

Strongbridge Biopharma

$2.77

-0.12 (-4.15%)

07:35
07/19/19
07/19
07:35
07/19/19
07:35
Hot Stocks
Strongbridge Biopharma announces new employment inducement awards »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$128.40

1.355 (1.07%)

07:35
07/19/19
07/19
07:35
07/19/19
07:35
Earnings
American Express reports Q2 EPS $2.07, consensus $2.04 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.